1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Haemophilus influenzae Meningitis Type B in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Scheld, WM; Townsend, GC | 1 |
| Arditi, M; Caplan, M; Manogue, KR; Yogev, R | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Haemophilus influenzae Meningitis Type B
| Article | Year |
|---|---|
Platelet-activating factor augments meningeal inflammation elicited by Haemophilus influenzae lipooligosaccharide in an animal model of meningitis.
Topics: Animals; Blood-Brain Barrier; Disease Models, Animal; Female; Lipopolysaccharides; Meningitis, Haemophilus; Platelet Activating Factor; Rats; Rats, Wistar | 1994 |
Cerebrospinal fluid cachectin/tumor necrosis factor-alpha and platelet-activating factor concentrations and severity of bacterial meningitis in children.
Topics: Adolescent; Bacteria; Cerebrospinal Fluid; Cerebrospinal Fluid Proteins; Child; Child, Preschool; Endotoxins; Humans; Infant; Lipopolysaccharides; Meningitis; Meningitis, Haemophilus; Platelet Activating Factor; Prospective Studies; Seizures; Tumor Necrosis Factor-alpha | 1990 |